抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號(hào) | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
GNE-493，98% | C17H20N6O2S | |||
|
|
|||||
|
PF-04979064，98% | C24H26N6O3 | |||
|
|
|||||
|
PI4KIII beta inhibitor 3，98% | C22H22N8OS | |||
|
|
|||||
|
ETP-46321，98% | C20H27N9O3S | |||
|
|
|||||
|
Duvelisib (R enantiomer)，98% | C22H17ClN6O | |||
|
|
|||||
|
MLN1117，95% | C19H17N5O3 | |||
|
|
|||||
|
CNX-1351，99% | C30H35N7O3S | |||
|
|
|||||
|
Seletalisib (UCB-5857)，≥99% | C23H14ClF3N6O | |||
|
|
|||||
|
PI4KIIIbeta-IN-9，98% | C23H25N3O5S2 | |||
|
|
|||||
|
CAL-130 (Hydrochloride)，98% | C23H23ClN8O | |||
|
|
|||||
|
OTSSP167 (hydrochloride)，98% | C25H29Cl3N4O2 | |||
|
|
|||||
|
HG-9-91-01，95% | C32H37N7O3 | |||
|
|
|||||
|
TGR-1202 (R-enantiomer)，98% | C31H24F3N5O3 | |||
|
|
|||||
|
Tenalisib，98% | C23H18FN5O2 | |||
|
|
|||||
|
NSC781406，99% | C29H27F2N5O5S2 | |||
|
|
|||||
|
IPI549，99% | C30H24N8O2 | |||
|
|
|||||
|
PI3Kδ-IN-2，98% | C28H37FN6O5S | |||
|
|
|||||
